Oncology & Cancer

Nanohyperthermia softens tumors to improve treatment

The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers. A team of researchers from CNRS, the French National Institute of Health and Medical Research (INSERM), ...

Oncology & Cancer

Common food additive promotes colon cancer in mice

Emulsifiers, which are added to most processed foods to aid texture and extend shelf life, can alter intestinal bacteria in a manner that promotes intestinal inflammation and colorectal cancer, according to a new study.

Oncology & Cancer

Estrogen signaling impacted immune response in cancer

While the role of estrogen signaling in tumor development is well understood in breast and ovarian cancer, its role in anti-tumor immunity has not been extensively studied. However, new research from The Wistar Institute ...

Genetics

Regulatory RNA essential to DNA damage response

Stanford researchers have found that a tumor suppressor known as p53 is stabilized by a regulatory RNA molecule called DINO. The interaction helps a cell respond to DNA damage and may play a role in cancer development and ...

Oncology & Cancer

Aggressive lung cancer's aggressiveness may be its Achilles' heel

Researchers at the University of Virginia School of Medicine have discovered a flaw in the armor of the most aggressive form of lung cancer, a weakness that doctors may be able to exploit to slow or even stop the disease. ...

page 11 from 28